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Abstract p94 cr and p51 cr are two nuclear tyrosine kinases 
encoded by the FER locus in the mouse. While p94 f er 
accumulates in somatic cells, p51 f c r l is found solely in meiotic 
spermatogenic cells. Ectopie expression of p94fer or p51 f erT in 
CHO cells, led to tyrosine phosphorylation of cellular 66, 68 and 
120 kDa proteins. A 120, 68 and 66 kDa phosphoproteins, 
coimmunoprecipitated with p94fer and p51 f erT from extracts of 
transfected CHO cells. Subcellular fractionation analysis 
indicated that the 66 kDa tyrosine phosphorylated protein co-
localizes with p51 f erT to perinuclear and nuclear fractions in 
actively growing cells. However, in growth arrested cells, the 66 
kDa phosphoprotein was associated mainly with chromatin while 
its level in the other nuclear compartments was significantly 
reduced. The 66 kDa phosphoprotein may thus mediate the 
nuclear function of the FER proteins and link it to cell growth. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The mouse F E R locus, originally identified through its ho-
mology to v. abl [1], encodes two tyrosine kinases. One, 94 
k D a in size (p94fer) is present in most mammalian somatic cell 
lines and is evolutionarily conserved [2,3]. p94fer can be de-
tected in both cell cytoplasm and chromatin [4]. The second 
tyrosine kinase, termed p51 f c r T , is encoded by a testis specific 
F E R transcript (ferT) and exhibits a molecular mass of 51 
k D a [5,6]. p51 f e r T accumulates in spermatocytes residing in 
prometaphase and metaphase of the first meiotic division 
[6,7]. Expression of p51 f e r T in C H O cells leads to its accumu-
lation in the nuclei of the transfected cells [7]. 
p94fcr and p51 f c r l share an identical SH2 sequence [8,9], and 
an identical kinase domain that is 70% homologous to the 
p92fes/fps kinase domain [5,10,11]. The two kinases differ, how-
ever, in their N-terminal portions. While the p51 f e r T N-termi-
nus is made up of 44 unique amino acids [5], that of p94fer 
consists of 350 amino acids. It adopts a coiled-coil structure 
which mediates the interaction of that kinase with the catenin-
like substrate p p l 2 0 [12]. Both enzymes have been partially 
characterized biochemically, yet their cellular functions, as 
well as their substrates, remain unknown. The kinase activity 
of the p94fer cytoplasmic fraction is elevated in growth factor 
stimulated fibroblastic cell lines [12], thus suggesting the pos-
sible involvement of p94 fcr in cell growth related processes. To 
further identify potential substrates of the FER proteins, the 
two tyrosine kinases were overexpressed in C H O cells, under 
the control of an inducible promoter . 
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In the present report, it is shown that ectopie expression of 
p94 fcr or p51 f c r T in somatic cell cultures leads to tyrosine 
phosphorylation of cellular 120, 68 and 66 k D a proteins. 
The subcellular distribution of the 66 k D a phosphoprotein 
depends on the growth state of the cells, thus supporting 
the linkage of the F E R proteins to modulation of cell growth. 
2. Materials and methods 
2.1. Plasmici construction 
The pHSlferT plasmid was constructed as follows: a BgUl-TthlUl 
ferT cDNA fragment [5] was rendered blunt-ended by extension poly-
merization using a Klenow fragment at its TiAIIIl end and was cloned 
into a Bglll-EcoRl restricted pECE plasmid [13], whose EcoKl end 
was blunt-ended as well. That plasmid was termed pECEferT. A 
BamHl-Bglll fragment containing the ferT cDNA linked to the 3' 
non-translated sequences of the early SV40 genes was excised from 
the pECEferT plasmid. It was then inserted in the BamHl site of a 
pUC18 plasmid (pHSl) carrying a human metallothionein IIA pro-
moter [14]. In the resultant pHSlferT plasmid, the ferT cDNA was 
transcribed under the control of the human metallothionein promoter. 
The pHSlfer plasmid was constructed by replacing an Spel-Clal frag-
ment in pHSlferT with an XBal-Cldl fragment from the mouse fer 
cDNA. This led to replacement of the p51fcrT N-terminus with the 
p94fer N-terminus. 
2.2. Cell culture and transfection 
CHO cells were cultured in F-12 medium, then co-transfected with 
1 ug PSV2neo [15] and 10 ug pHSlferT or pHSlfer plasmids, using 
the calcium phosphate precipitation technique [16]. G418-resistant 
clones [15] were further grown, exposed for 18 h to 100 uM ZnCl2 
and analyzed for accumulation of p94fcr or p51 fc lT. For FER protein 
expression in growth arrested cells, cells were grown to confluency. 
The cells were left in culture for a further 24 h during which they were 
exposed for 18 h to 100 |xM ZnCl2. The accumulation of more than 
90% of the cells in the G0/G1 cell cycle stage, was confirmed by 
exposing the cells to flow cytometry analysis. 
2.3. Preparation of cell protein extracts 
For total cell protein extracts, cells were lysed using triple detergent 
lysis buffer as described [17]. Subcellular fractionation extracts were 
carried out essentially according to Peraness et al. [18] with the fol-
lowing modifications. Pellets of 2X107 cells were lysed with 1 ml 
HEPES buffer [10 mM HEPES (pH 7.4), 0.25 M sucrose, 2 mM 
EDTA, 0.1 mM dithiothreitol, 0.1 mM PMSF, 0.1 mM Na3V04 , 
0.1% Nonidet P40 and 10 ug/ml each of Pefabloc SC, leupeptin, 
aprotinin (Boehringer Mannheim) and benzamidine (Sigma)]. Nuclei 
were spun down and cytoplasmic supernatants were removed and 
stored. Perinuclear proteins were extracted from nuclei which were 
suspended in a buffer containing 10 mM HEPES (pH 7.4), 0.25M 
sucrose, 2 mM MgCl2, 0.1% Triton X-114, 0.1 mM PMSF, 0.1 mM 
Na3"VC>4 and 5 |ig/ml each of Pefabloc SC, leupeptin, aprotinin and 
benzamidine. Nucleoplasmic proteins were extracted by washing the 
nuclei with a buffer containing 10 mM HEPES (pH 7.4), 0.25 M 
sucrose, 0.5% Nonidet P-40, 0.1 mM Na3V04 , 0.1 mM PMSF and 
10 ug/ml each of Pefabloc SC, leupeptin, aprotinin and benzamidine. 
After extracting the nuclei with the same buffer containing 1% Non-
idet P-40 and digesting the DNA with micrococcal nuclease, chroma-
tin-associated proteins were extracted with a high salt buffer (3.5 M 
NaCl, 1% Nonidet P-40, 10 mM EDTA, 0.1 mM Na3V04 , 0.1 mM 
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PMSF). The nuclear matrix was solubilized by boiling in 1% SDS. 
The total protein amounts, obtained in the different fractions were as 
follows: CY1, first cytoplasmic wash, about 2 mg; PN, perinuclear 
fraction, about 1.5 mg; NP1, nucleoplasmic fraction 1, about 1.25 
mg; CH, chromatin fraction, about 1 mg; NM, the nuclear matrix 
fraction, 0.8 mg. The similar total protein amounts in the prepared 
fractions enabled us to analyze similar samples (30 (ig) from each 
fraction. These samples therefore represent similar numbers of cells 
in each fraction. 
2.4. Western blot analysis 
Cellular protein extracts (30 |xg) were resolved in SDS-polyacryl-
amide (9%) gels. Proteins were electroblotted onto a nitrocellulose 
membrane and incubated with a monoclonal anti-phosphotyrosine 
(clone: PT-66) antibody (Biomakor cat. no. 6093) at a 1:10000 dilu-
tion, with Ci antibody at a 1:5000 dilution or with eIF-4A antibodies 
at 1:500 dilution. The bands were visualized with the ECL Western 
blotting (RPN 2106) analysis system (Amersham International). 
2.5. Immunoprecipitation and in vitro kinase assays 
Extracts for immunoprecipitations and in vitro kinase assays were 
prepared as follows: Cells were lysed with lysis buffer (10 mM HEPES 
pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.1% Triton X-114, 0.1 mM 
NaäV04 and 10 |J,g/ml each of Pefabloc SC, leupeptin, aprotinin and 
benzamidine), the extracts were spun down and supernatants were 
brought to 20% glycerol. For immunoprecipitation and kinase assay, 
200 u.g of protein extracts were resuspended in HNTG buffer ( X 2) 
and precipitated with a 1:50 dilution of Ci or Ni antibody at 4°C for 
3 h. Immunocomplexes were incubated with protein A-Sepharose 
(Sigma) at 4°C for 2 h. The antibody-protein Sepharose conjugates 
were washed twice with HNTG buffer (20 mM HEPES pH 7.5, 150 
mM NaCl, 0.1% Triton X-100, 10% glycerol) and once with MHNG 
buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM 
MgCt and 5 mM MnCl2). The conjugates were resuspended in 50 ul 
MHNG buffer containing 50 mM HEPES pH 7.5 and 3 ul [y-32P]ATP 
(3000 Ci/mmol) was added for 30 min at room temperature. 
Samples were resolved in SDS-polyacrylamide (9%) gels, electro-
blotted onto Immobilon (PVDF) membrane and treated for 2 h at 
55°C with 1 M KOH as described before [19]. Membranes were ex-
posed to Fuji medical X-ray film. 
For Western blot analysis of immunoprecipitated proteins, immu-
noprecipitates were resolved in 9% SDS-PAGE after two HNTG 
washes (see above). 
3. Results and discussion 
3.1. Regulation of cellular protein tyrosine phosphorylation by 
p94ia andp51felT 
The mouse p94fer and p51 f e r T cDNAs were linked to the 
Fig. 1. (A) Exogenous expression of p94fer and p51ferT in transfected 
CHO cells. 30 |xg of whole cell protein extracts prepared from 
clones 51.3-3 (1,2) and 51.3-4(3,4) which were transfected with 
pHSlfer (p94fer), or clones 32.4-2(5,6) and 32.4-3(7,8) transfected 
with pHSlferT (p51ferT), before ( - ) and after (+) 100 uM ZnCl2 
treatment, were fractionated in a 9% SDS-PAGE. Proteins were 
electroblotted to a nitrocellulose membrane and incubated with Cl 
antibodies. Arrows on the left indicate migration distances of p94fer 
and p51ferT. Migration distances of known molecular weight 
markers are given on the right. (B) Phosphorylation state of pro-
teins, in extracts untreated with vanadate from pHSlfer and 
pHSlferT cells. 30 ug whole cell protein extracts from clones trans-
fected with pHSlfer (51.3-3, 51.3.3-4) or pHSlferT (32.4-2), before 
(—) and after (+) 100 uM ZnCl2 treatment, were Western blotted 
and reacted with monoclonal anti-phosphotyrosine antibodies. Ar-
rows on the left indicate migration distances of 66 and 65 kDa 
phosphoproteins. Migration distances of known molecular weight 
markers are given on the right. (C) Phosphorylation state of pro-
teins, in extracts treated with vanadate from pHSlfer and pHSl 
transfected cells. Protein extracts described in A were fractionated 
in a 9% SDS-PAGE, Western blotted and reacted with monoclonal 
anti-phosphotyrosine antibodies. Arrows indicate migration distan-
ces of 66 and 120 kDa phosphoproteins. 
human metallothionein IIA promoter [14] to construct the 
pHSlfer and pHSlfe rT plasmids, respectively. These were sta-
bly introduced into C H O cells. Western blot analysis of ly-
sates of clonai transfected cell lines showed that both proteins 
were identified with antibodies ( Q ) raised against a synthetic 
peptide derived from the last common 15 C-terminal amino 
acids of p94 fer and p51 f e r T [5]. Fig. 1 demonstrates that both 
clones expressing p94fer (Fig. 1, lanes 1-4) and those express-
ing p51 t e r T (Fig. 1, lanes 5-8) accumulated the exogenous 
enzymes in a ZnCl2-dependent manner. A similar expression 
pattern was observed in several other clones which were ana-
lyzed (data not shown). N o significant level of endogenous 
p94fer could be detected in non-transfected cells or in unin-
duced transfected cells (Fig. 1A). This may reflect either low 
cellular levels of endogenous p94 fe r, or a lack of cross-reac-
O. Bern et allFEBS Letters 403 (1997) 45-50 47 
Fig. 2. Subcellular localization of the 66 kDa phosphoprotein. 30 ug proteins from subcellular fractions of non-induced (A), induced (B) ac-
tively growing and induced growth arrested (C) 32.4-2 pHSlferT cells, were blotted and incubated with monoclonal anti-phosphotyrosine anti-
bodies. CYl, cytoplasmic fraction; CY2, cytoplasmic wash; PN, perinuclear fraction; NPl , nuclear plasmic fraction; NP2, second nuclear plas-
mic wash; CH, chromatin associated proteins; NM, nuclear matrix. Arrow on the left indicates migration distance of the 66 kDa 
phosphotyrosine protein. Migration distances of known molecular weight markers are given on the right. 
tivity between the endogenous hamster p94fer and the anti-
bodies used in this work. 
The effects of p94fer and p51ferT overexpression, on the ty-
rosine phosphorylation pattern of cellular proteins, were 
studied using monoclonal anti-phosphotyrosine antibodies. 
Whole cell protein extracts were prepared with buffer lacking 
vanadate, from clones transfected with p94fer or p51ferT cDNA 
before and after ZnCl2 treatment. The proteins were separated 
on 9% SDS-PAGE, Western blotted and exposed to anti-
phosphotyrosine antibodies (Fig. IB). A 66 kDa protein be-
came tyrosine phosphorylated in the clones expressing p51ferT, 
upon exposing the cells to ZnCl2 (Fig. IB, lanes 5,6). No such 
effects could be detected in the parental non-transfected cells, 
in cells expressing exogenous mutant p51ferT deleted of its 
kinase domain (data not shown) or in cells transfected with 
the pHSl plasmid lacking any FER cDNA (Fig. 1C, lane 1). 
In clones expressing p94fer, two proteins of similar molec-
ular mass (~66 kDa) underwent tyrosine phosphorylation 
concomitantly with the accumulation of p94fer in these cells 
(Fig. IB, lanes 1^1). These phosphotyrosyl levels were signifi-
cantly lower than those of the 66 kDa band, detected in ex-
tracts prepared from clones expressing p51ferT (Fig. IB, lanes 
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Fig. 3. Subcellular localization of eIF-4A in non-induced (A) and 
induced (B) 32.4-2 pHSlferT cells. Proteins from the same fractions 
as described in Fig. 2 were Western blotted and reacted with elF-
4A antibodies. Arrow on the left indicates migration distance of 
eIF-4A. 
5,6). This phenomenon can be clearly seen in clones 51.3-3 
and 32.4-2 which expressed comparable levels of p94fer and 
p51 t e rT, respectively, but exhibited significantly different levels 
of phosphotyrosine, associated with the 66 kDa protein (Fig. 
IB). Inclusion of vanadate to suppress phosphatases in pro-
tein extraction buffer did not change the relative expression 
levels of p94fer and p51ferT (data not shown) but led to tyro-
sine phosphorylation of additional 68 and 120 kDa proteins 
(Fig. 1C). The exact migration distance of the 68 kDa phos-
phoprotein varied in some experiments, a fact which may 
reflect several potential phosphorylation levels of that protein. 
Unlike the 66 and 68 kDa proteins, the tyrosine phosphoryl-
ation levels of the 120 kDa protein were similar in clones 
expressing p51ferT or p94fer (Fig. 1C, lanes 2,3). Although 
p94fer and p51ferT seemed to be active in the G418-resistant 
clones, the proteins were not significantly autophosphorylated 
in that system. No obvious tyrosine phosphorylated proteins 
corresponding in size to either p94fer or p51ferT could be de-
tected in the transfected ZnC^-treated clones (Fig. 1B,C). 
3.2. Subcellular localization of the 66 kDa phosphoprotein 
It has previously been reported that p51ferT and approx. 
50% of the cellular p94fer molecules are located in the cell 
nucleus [4,7]. We therefore sought to characterize the subcel-
lular localization of the 120, 66 and 68 kDa phosphoproteins 
and to determine whether they co-localize with p94fer or 
p51ferT. Clones expressing p94fer and p51ferT were lysed with 
vanadate-containing buffer and were biochemically fraction-
ated to subcellular constituents. Proteins extracted from each 
fraction were Western blotted and exposed to anti-phospho-
tyrosine antibodies. The 120 and 68 kDa phosphoproteins 
could not be reproducibly detected in the prepared fractions. 
This may reflect the high sensitivity of these phosphoproteins 
to cellular dephosphorylation activities (Fig. 1) Detectable 
levels of the 66 kDa phosphoprotein were obtained in frac-
tions prepared from induced p51ferT expressing clones only 
(Fig. 2). The 66 kDa phosphoprotein was not detected in 
fractions prepared from p94fer expressing clones (data not 
shown). This could result from the relatively low phosphoryl-
ation levels of the 66 kDa phosphoprotein or low concentra-
tions of the 66 kDa protein in these cells. In clones expressing 
p51ferT, the 66 kDa phosphoprotein associated mainly with 
the cell perinuclear and nuclear cytosolic fractions (Fig. 2B). 
However, it was not detected in other nuclear compartments 
like chromatin and nuclear matrix (Fig. 2B, lanes 67). Probing 
the same fractions with antibodies to p51ferT, revealed an 
identical subcellular distribution of p51ferT and the 66 kDa 
phosphoprotein in transfected cells (data not shown). This 
coincides with previous subcellular localization experiments 
of p51ferT, in transfected CHO cells [7]. The presence of the 
66 kDa protein in the perinuclear fraction may reflect its 
association with the nuclear or other cellular membranes. Al-
ternatively, it may reflect leakage of the 66 kDa phosphopro-
tein from the intranuclear environment, due to detergent in-
clusion in the extraction procedure adopted in these 
experiments (see also Section 2). The subcellular localization 
of the 66 kDa phosphoprotein differed, however, from the 
distribution profile of eIF-4A, a soluble cytoplasmic transla-
tion initiation factor [20], which is equally present in the cy-
toplasmic and perinuclear fractions in induced and non-in-
duced cells (Fig. 3A,B). The absence of the 66 kDa 
phosphoprotein from the soluble cytoplasmic fractions indi-
cates that it is associated mainly with either the nuclear cyto-
sol or cellular membranes. An additional 60 kDa phospho-
protein was detected in perinuclear and nuclear fractions of 
p51ferT expressing clones (Fig. 2B). This could reflect degra-
dation or partial dephosphorylation of the 66 kDa phospho-
protein. The 66 kDa phosphoprotein was not detected in non-
induced clones (Fig. 2A) or in CHO cells transfected with 
pHSl plasmid lacking a FER cDNA (data not shown). The 
cellular levels of p94fer do not change along the cell division 
cycle of fibroblastic cells (Bern and Nir, unpublished data). 
The enzyme is, however, activated in growth factor stimulated 
fibroblasts [11]. The functioning of the FER pathway constit-
uents may thus vary in growing and quiescent cells. The rel-
ative phosphotyrosyl levels and the subcellular distribution 
profile of the 66 kDa phosphoprotein were therefore analyzed 
in growth arrested quiescent cells. The induced production of 
p51ferT in confluent growth arrested cells led to significant 
reduction in the 66 kDa phosphotyrosyl levels in the perinu-
clear and nuclear fractions (Fig. 2C). Unlike in growing cells, 
however, a 66 kDa phosphoprotein was clearly detected in the 
chromatin fraction of the p51ferT expressing cells (Fig. 2C). 
That phosphoprotein was not detected in non-induced conflu-
ent cells (data not shown), thus linking its appearance to the 
activity of p51 t e rT. The subnuclear localization of p51ferT and 
the subcellular distribution of eIF-4A did not change in 
growth arrested cells (data not shown). The different subnu-
clear localization of a 66 kDa phosphoprotein in growing and 
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Fig. 4. Coimmunoprecipitation of cellular phosphoproteins with p94fer and p51ferT. (A) Whole cell proteins from neo resistant CHO cells 
(PHSl) and CHO cells expressing p51ferT (PHSlferT) were immunoprecipitated with Nl antibodies. Precipitated proteins were exposed to in vi-
tro kinase assay in the presence of [y-32P]ATP. Phosphorylated proteins were resolved on 9% SDS-PAGE, transferred to PVDF (immobilon) 
membrane which was then treated for 2 h at 55°C with 1 M KOH. Membranes were exposed to Fuji X-ray medical film. Arrows indicate mi-
gration distances of p51ferT and its putative 68 kDa substrate. (B) Whole cell proteins from PHSl (lane 1) and mouse p51ferT expressing cells 
(lane 2), were immunoprecipitated with Nl antibodies. Precipitated proteins were Western blotted and reacted with monoclonal anti-phospho-
tyrosine antibodies. Arrows indicate migration distances of the 66, 68 and 120 kDa phosphoproteins. Ab denotes precipitating antibodies which 
react with the peroxidase conjugated protein A. (C) Whole cell proteins from PHSl (lane 1), mouse p51ferT expressing cells (lane 2), and mouse 
p94fer expressing cells (lane 3) were immunoprecipitated with Cl antibodies. Precipitated proteins were Western blotted and reacted with mono-
clonal anti-phosphotyrosine antibodies. Arrows denote calculated molecular weights of precipitated proteins. Ab denotes the precipitating anti-
bodies which react with the peroxidase conjugated protein A. (D) Whole cell proteins from CHO cells expressing the mouse p94fer (lane 1) or 
pjiferT (iane 2) were immunoprecipitated with antiserum E. Precipitated antibodies were exposed to in vitro kinase assay in the presence of 
[y-32P]ATP. Phosphorylated products were resolved on 9% SDS-PAGE and transferred to PVDF membrane. The membrane was treated with 
1 M KOH, at 55°C for 2 h, dried and exposed to Fuji medical X-ray film. Arrow on the left indicates migration distance of the mouse p94ter. 
quiescent cells which express p51ferT suggests the possible in-
volvement of the FER proteins in the modulation of nuclear 
processes, related to cell growth. This may also apply to mei-
otic cells which endogenously express p51ferT [7], and in which 
some somatic nuclear processes like DNA replication are sup-
pressed [21]. Indeed, induced expression of p51ferT in CHO 
cells elongated their S phase and consequently slowed down 
the division rate of these cells (data not shown). 
3.3. p94fei and p51tevT associate with tyrosine phosphorylated 
66, 68 and 120 kDa proteins in growing cells 
The subcellular co-localization of p51ferT and the 66 kDa 
phosphoprotein in growing cells suggests that these two pro-
teins associate in vivo. To check this possibility, the coimmu-
noprecipitation of tyrosine phosphorylated cellular proteins 
with the FER enzymes was tested. The in vitro phosphoryla-
tion pattern of cellular proteins, coimmunoprecipitated with 
p94fer and p51ferT, was studied as well. Q antibodies raised 
against the C-terminus of p94fer and p51ferT, immunoprecipi-
tated these enzymes but interfered with their in vitro auto-
phosphorylation activity (data not shown). This coincides 
with previous results which indicated that antiserum G, raised 
against the C-terminus of p94fer, did not allow autophospho-
rylation of the immunoprecipitated enzyme [3]. The interfer-
ence of Ci antibodies with the autophosphorylation of the 
FER proteins suggests the possible localization of the tyrosine 
autophosphorylation acceptor site to the C-terminus of these 
proteins. A similar localization of the autophosphorylation 
acceptor site was established in p93c_fes [22], which is closely 
related to the FER proteins. Two other antisera raised against 
p94fer and p51ferT were therefore used for the immunocomplex 
kinase assays. Ni antibodies, raised against a synthetic pep-
tide (Glun-Lys24) derived from the unique N-terminus of 
pjiferT rj^ w e r e u s e c j t 0 imrrmrioprecipitate this enzyme 
from extracts of p51ferT expressing cells. These antibodies do 
not interact with p94fer [7]. An in vitro kinase assay carried 
out with the immunoprecipitated proteins led to tyrosine 
phosphorylation of a 51 kDa protein, and an additional pro-
tein of approx. 68 kDa. The relatively broad 68 kDa band 
may reflect, as mentioned above, several phosphorylation lev-
els ofthat protein (Fig. 4A, lane 2). The 51 and 68 kDa bands 
were not detected in precipitates from pHSl cell (harboring 
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the parental SVneo gene containing plasmid) extracts (Fig. 
4A, lane 1) indicating that the 51 kDa protein is p51ferT and 
the 68 kDa protein represents its putative, associated sub-
strate. 
Immunoprecipitation of p94fer with antiserum E [3] and 
analysis of its activity in an in vitro kinase assay led to auto-
phosphorylation of that enzyme (Fig. 4D, lane 1). No addi-
tional cellular protein with an apparent different molecular 
weight was phosphorylated by this enzyme in an in vitro kin-
ase assay. This coincides with previous results obtained in in 
vitro kinase assays carried out with antiserum E precipitates 
[3]. Since antiserum E was raised against the N-terminal half 
of the FER protein's SH2 domain [3], it may interfere with the 
interaction of these enzymes and their putative substrates. The 
autophosphorylation activity of p51ferT is much weaker than 
that of p94fer and was barely detected in the immunokinase 
assay (Fig. 4D, lane 2). Longer exposure of the dried gel 
revealed weak autophosphorylation activity of p51ferT in 
Fig. 4D, lane 2 (data not shown). 
To verify the association of the 66 kDa phosphotyrosyl 
protein with p51 terT in vivo, cellular proteins were immuno-
precipitated with Ni antibodies from pHSl and p51ferT ex-
pressing cells. The precipitated proteins were fractionated in 
SDS-PAGE, Western blotted, and reacted with monoclonal 
anti-phosphotyrosine antibodies. In Fig. 4B, it can be seen 
that 66, 68 and 120 kDa tyrosine phosphorylated proteins 
coimmunoprecipitated with p51ferT. These proteins were not 
detected in immunoprecipitates from pHSl cells. The Q anti-
bodies, raised against the common C-terminus of p94fer and 
p51ferT, coimmunoprecipitated these enzymes with 66, 68 and 
120 kDa tyrosine phosphorylated proteins as well (Fig. 4C). 
While the 120 kDa phosphotyrosyl band appeared in similar 
levels in p94fer and p51ferT precipitates (Fig. 4C, lanes 2,3), the 
66 and 68 kDa phosphotyrosyl bands appeared in much high-
er levels in p51ferT precipitates as compared with p94fer pre-
cipitates. The 66 and 68 kDa bands may represent two differ-
ent proteins or alternatively two phosphorylation levels of the 
same protein. The coimmunoprecipitation of a 66 kDa protein 
and p51ferT, by antibodies directed toward either the N- or C-
terminus of this enzyme, strongly suggests the association of 
p51ferT and a 66 kDa tyrosine phosphorylated protein, in vivo. 
Stable in vivo association of the cytoplasmic src [23,24] and 
the nuclear c-abl [25] with their putative substrates in vivo has 
been shown before. This association may play a role in mod-
ulating the turnover activity of cytoplasmic and nuclear tyro-
sine kinases. 
The subcellular distribution of the 66 kDa phosphoprotein 
in growing cells is identical to the subcellular localization of 
the human GAP-associated p62 protein [26]. In addition, the 
stable association of the 66 kDa protein with p51ferT in vivo 
resembles the tight association of the p62 related protein (p68) 
with c-src in vivo [23,24]. Commercially available (Santa Cruz 
Biotechnology) anti- p62 antibodies were used for Western 
blot analysis, and failed to detect any protein in p51ferT pre-
cipitates (data not shown), suggesting that the 66 kDa phos-
phoprotein differs from the previously cloned p62 and p68 
proteins [23,24,26]. She antibodies (Santa Cruz Biotechnol-
ogy) also failed detect any protein in the p51ferT precipitates 
(data not shown). 
The catenin-like substrate ppl20 was previously shown to 
associate in vivo with p94fer [11]. Since ppl20 interacts with 
p94fer through the unique N-terminus of the enzyme, the 120 
kDa phosphoprotein associated with p51ferT, seems to be of 
another identity. Antibodies (Santa Cruz Biotechnology) di-
rected against other known 120 kDa tyrosine phosphorylated 
proteins, like ras GTPase-activating protein (GAP) and FAK, 
failed to detect any protein in the p51ferT immunoprecipitates 
(data not shown). Further characterization of the presently 
described 66, 68 and 120 kDa phosphoproteins should offer 
new tools for elucidating the nuclear functions of the FER 
proteins. 
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